glp 1 fda compounding GLP-1 Medications – Guidance and Compounded Products Novo asks FDA to prevent

Other studies have found that taking glutathione at 250 or 1000 mg/day led to increased glutathione levels [37]

Those experiencing gastrointestinal side effects may benefit from oral rehydration solutions or electrolyte-containing beverages

A separate Phase 2 trial in type 2 diabetes evaluated retatrutide against placebo and an active comparator, reporting clinically meaningful reductions in HbA1c together with weight loss across the dose range

The increases were relatively small, but researchers say they highlight the need for physicians to closely monitor patients on GLP-1s and suggest interventions when necessary and for patients to make lifestyle changes that can boost bone and joint health

This uncertainty is one of the challenges with using compounds that lack regulatory approval